Effect of Chewing vs Swallowing Ticagrelor on Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial

IMPORTANCE: Dual anti-platelet therapy represents standard care for treating patients with ST-segment elevation myocardial infarction (STEMI). Ticagrelor is a direct-acting P2Y12 inhibitor and, unlike clopidogrel and prasugrel, does not require metabolic activation. OBJECTIVE: To evaluate whether ch...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Cardiol
Main Authors: Asher, Elad, Tal, Shir, Mazin, Israel, Abu-Much, Arsalan, Sabbag, Avi, Katz, Moshe, Regev, Ehud, Chernomordik, Fernando, Guetta, Victor, Segev, Amit, Elian, Dan, Barbash, Israel, Fefer, Paul, Narodistky, Michael, Beigel, Roy, Matetzky, Shlomi
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5814990/
https://ncbi.nlm.nih.gov/pubmed/29071332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2017.3868
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados